High dose of antacid reduces bioavailability of ranitidine.
作者信息
Frislid K, Berstad A
出版信息
Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1358. doi: 10.1136/bmj.286.6374.1358-b.
Abstract
摘要
相似文献
1
High dose of antacid reduces bioavailability of ranitidine.高剂量抗酸剂会降低雷尼替丁的生物利用度。
Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1358. doi: 10.1136/bmj.286.6374.1358-b.
2
High dose of antacid (Mylanta II) reduces bioavailability of ranitidine.高剂量抗酸剂（胃仙-U）会降低雷尼替丁的生物利用度。
Br Med J (Clin Res Ed). 1982 Oct 9;285(6347):998-9. doi: 10.1136/bmj.285.6347.998.
3
Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers.对健康志愿者口服400毫克剂量莫西沙星后，抗酸剂和H2拮抗剂对其吸收影响的评估。
Clin Pharmacokinet. 2001;40 Suppl 1:39-48. doi: 10.2165/00003088-200140001-00006.
4
Oral bioavailability of nizatidine and ranitidine concurrently administered with antacid.尼扎替丁和雷尼替丁与抗酸剂同时给药时的口服生物利用度。
J Int Med Res. 1989 Jan-Feb;17(1):62-7. doi: 10.1177/030006058901700109.
5
6
Effects of antacids on the clinical pharmacokinetics of drugs. An update.抗酸剂对药物临床药代动力学的影响。最新进展。
Clin Pharmacokinet. 1990 Mar;18(3):210-9. doi: 10.2165/00003088-199018030-00003.
7
Effects of ranitidine (antacid), food, and formulation on the pharmacokinetics of fostamatinib: results from five phase I clinical studies.雷尼替丁（抗酸剂）、食物及制剂对福司替尼药代动力学的影响：五项I期临床研究结果
Eur J Clin Pharmacol. 2017 Feb;73(2):185-195. doi: 10.1007/s00228-016-2156-4. Epub 2016 Nov 17.
8
Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid.
Tuberculosis (Edinb). 2004;84(6):365-73. doi: 10.1016/j.tube.2004.04.001.
9
[Bioavailability and buffer capacity of antacids. A randomized double-blind study for the comparison of the most used antacid solutions].
Fortschr Med. 1981 Sep 3;99(33):1318-20.
10
Ranitidine as an antacid in elective cesarean delivery and its placenta transfer--a preliminary report.雷尼替丁作为择期剖宫产术中的抗酸剂及其胎盘转运——初步报告。
Ma Zui Xue Za Zhi. 1985 Mar;23(1):18-21.
引用本文的文献
1
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.胃食管反流病治疗中的药代动力学优化
Clin Pharmacokinet. 1996 Nov;31(5):386-406. doi: 10.2165/00003088-199631050-00005.
2
Clinical pharmacokinetics of ranitidine.雷尼替丁的临床药代动力学。
Clin Pharmacokinet. 1984 May-Jun;9(3):211-21. doi: 10.2165/00003088-198409030-00003.
3
Effect of aluminum phosphate on the bioavailability of ranitidine.磷酸铝对雷尼替丁生物利用度的影响。
Eur J Clin Pharmacol. 1987;32(1):97-9. doi: 10.1007/BF00609966.
4
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.雷尼替丁。对其药效学、药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗应用的最新综述。
Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003.
5
Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).用于治疗胃肠道疾病的药物的临床药代动力学（第二部分）。
Clin Pharmacokinet. 1990 Aug;19(2):94-125. doi: 10.2165/00003088-199019020-00002.
6
Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.组胺H2受体拮抗剂的药代动力学和药效学特性。内在活性与有效血药浓度之间的关系。
Clin Pharmacokinet. 1991 Mar;20(3):218-36. doi: 10.2165/00003088-199120030-00004.
本文引用的文献
1
Cimetidine plasma concentration-response relationships.西咪替丁血浆浓度-反应关系。
Clin Pharmacol Ther. 1981 Jun;29(6):744-8. doi: 10.1038/clpt.1981.105.
2
Controlled clinical trial of duodenal ulcer healing with antacid tablets.
Scand J Gastroenterol. 1982 Oct;17(7):953-9. doi: 10.3109/00365528209181120.
3
Relationship between ranitidine plasma levels and reduction of postprandial intragastric acidity in healthy man.健康男性中雷尼替丁血浆水平与餐后胃内酸度降低之间的关系。
Scand J Gastroenterol. 1982 Jan;17(1):109-12. doi: 10.3109/00365528209181053.
Zotero 插件